Your browser doesn't support javascript.
loading
Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorder.
Bartova, Lucie; Fugger, Gernot; Dold, Markus; Kautzky, Alexander; Fanelli, Giuseppe; Zanardi, Raffaella; Albani, Diego; Weidenauer, Ana; Rujescu, Dan; Souery, Daniel; Mendlewicz, Julien; Montgomery, Stuart; Zohar, Joseph; Fabbri, Chiara; Serretti, Alessandro; Kasper, Siegfried.
Affiliation
  • Bartova L; Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria; Department of Biomedical and NeuroMotor Sciences, University of Bologna, Bologna, Italy; Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria.
  • Fugger G; Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria; Department of Biomedical and NeuroMotor Sciences, University of Bologna, Bologna, Italy; Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria; Psychi
  • Dold M; Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria; Department of Biomedical and NeuroMotor Sciences, University of Bologna, Bologna, Italy; Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria.
  • Kautzky A; Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria; Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria.
  • Fanelli G; Department of Biomedical and NeuroMotor Sciences, University of Bologna, Bologna, Italy; Department of Human Genetics, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, the Netherlands.
  • Zanardi R; Vita-Salute San Raffaele University, Milano, Italy; Mood Disorders Unit, IRCCS Scientific Institute Ospedale San Raffaele, Milano, Italy.
  • Albani D; Laboratory of Biology of Neurodegenerative Disorders, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
  • Weidenauer A; Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria; Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria.
  • Rujescu D; Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria; Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria.
  • Souery D; Psy Pluriel - European Centre of Psychological Medicine, Brussels, Belgium; School of Medicine, Free University of Brussels, Brussels, Belgium.
  • Mendlewicz J; School of Medicine, Free University of Brussels, Brussels, Belgium.
  • Montgomery S; Imperial College School of Medicine, University of London, London, United Kingdom.
  • Zohar J; Psychiatric Division, Chaim Sheba Medical Center, Tel Hashomer, Israel.
  • Fabbri C; Department of Biomedical and NeuroMotor Sciences, University of Bologna, Bologna, Italy; Social, Genetic & Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.
  • Serretti A; Department of Biomedical and NeuroMotor Sciences, University of Bologna, Bologna, Italy.
  • Kasper S; Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria; Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria; Social, Genetic & Developmental Psychiatry Centre, Institute of Psychiatry, Psychology &amp
J Affect Disord ; 332: 105-114, 2023 07 01.
Article in En | MEDLINE | ID: mdl-36958488

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Depressive Disorder, Major / Serotonin and Noradrenaline Reuptake Inhibitors Type of study: Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Affect Disord Year: 2023 Document type: Article Affiliation country: Austria Country of publication: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Depressive Disorder, Major / Serotonin and Noradrenaline Reuptake Inhibitors Type of study: Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Affect Disord Year: 2023 Document type: Article Affiliation country: Austria Country of publication: Netherlands